Antigen presented by tumors in vivo determines the nature of CD8+ T-cell cytotoxicity. | Profiles RNS

RCMI Coordinating Center (RCMI CC)

Antigen presented by tumors in vivo determines the nature of CD8+ T-cell cytotoxicity.

Shanker A, Brooks AD, Jacobsen KM, Wine JW, Wiltrout RH, Yagita H, Sayers TJ. Antigen presented by tumors in vivo determines the nature of CD8+ T-cell cytotoxicity. Cancer Res. 2009 Aug 15; 69(16):6615-23.

View in: PubMed

authors with profiles

Anil Shanker

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support